CLBFX
Price
$40.96
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
VWELX
Price
$47.63
Change
+$0.03 (+0.06%)
Updated
Jun 2 closing price
Net Assets
121.34B
Interact to see
Advertisement

CLBFX vs VWELX

Header iconCLBFX vs VWELX Comparison
Open Charts CLBFX vs VWELXBanner chart's image
CLBFX vs VWELX Comparison Chart in %
View a ticker or compare two or three
VS
CLBFX vs. VWELX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Hold and VWELX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 279B vs. VWELX (121B). VWELX (1.95) and CLBFX (1.92) have matching dividends . CLBFX was incepted earlier than VWELX: CLBFX (24 years) vs VWELX (97 years). CLBFX (0.66) is less costly to investors than VWELX (0.24). VWELX is a more actively managed with annual turnover of: 62.00 vs. CLBFX (50.00). CLBFX has a lower initial minimum investment than VWELX: CLBFX (250) vs VWELX (3000). CLBFX annual gain was more profitable for investors over the last year : 17.91 vs. VWELX (10.17). CLBFX return over 5 years is better than : 38.25 vs. VWELX (5.00).
CLBFXVWELXCLBFX / VWELX
Total Expense Ratio0.660.24275%
Annual Report Gross Expense Ratio0.660.24275%
Fund Existence24 years97 years-
Gain YTD9.7866.833143%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets279B121B231%
Annual Yield % from dividends1.921.9599%
Returns for 1 year17.9110.17176%
Returns for 3 years46.1722.17208%
Returns for 5 years38.255.00765%
Returns for 10 years101.6338.03267%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX38.78N/A
N/A
ProFunds Biotechnology UltraSector Svc
VITPX125.26N/A
N/A
Vanguard Instl Ttl Stk Mkt Idx InstlPls
HFMCX21.38N/A
N/A
Hartford MidCap A
HWMIX67.23N/A
N/A
Hotchkis & Wiley Mid-Cap Value I
GSEPX73.92N/A
N/A
Goldman Sachs US Equity Insights P